References

Joint Royal Colleges Ambulance Liaison Committee (JRCALC) UK Ambulance Services Clinical Practice Guidelines: Flumazenil injection.Bridgwater: Class Professional Publishing; 2021

Baandrup L, Ebdrup BH, Rasmussen JØ, Lindschou J, Gluud C, Glenthøj BY. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev. 2018; 3:(3) https://doi.org/10.1002/14651858.CD011481.pub2

Chacko B, Peter JV. Antidotes in poisoning. Indian J Crit Care Med. 2019; 23:S241-S249 https://doi.org/10.5005/jp-journals-10071-23310

Conley K, Murphy-Parker D, Conley V. Increasing awareness of naloxone-induced noncardiogenic pulmonary and peripheral edema. CNS Spectrums. 2023; 28:(2)241-242 https://doi.org/10.1017/S1092852923001736

Dart RC, Borron SW, Caravati EM Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2009; 54:(3)386-394.e1 https://doi.org/10.1016/j.annemergmed.2009.01.023

Davies J. Flumazenil. In: Enna JS, Bylund DB. Boston (MA): Elsevier; 2007 https://doi.org/10.1016/B978-008055232-3.61759-3

Handal KA, Schauben JL, Salamone FR. Naloxone. Ann Emerg Med. 1983; 12:(7)438-445 https://doi.org/10.1016/S0196-0644(83)80343-6

Koski A, Ojanperä I, Vuori E. Alcohol and benzodiazepines in fatal poisonings. Alcohol Clin Exp Res. 2002; 26:(7)956-959 https://doi.org/10.1111/j.1530-0277.2002.tb02627.x

Kuang D, Ronco C, Hoenich N. Poisoning: kinetics to therapeutics, 2nd edn. In: Ronco C, Bellomo R, Kellum JA. Philadelphia, PA: Saunders Elsevier; 2009 https://doi.org/10.1016/B978-1-4160-4252-5.50184-2

McMenamin EM. Appropriate use of naloxone in the clinical setting. J Nurse Pract. 2012; 8:(5)394-398 https://doi.org/10.1016/j.nurpra.2012.02.015

Moon S, Mariat S, Kamae I, Pedersen HB. Defining the concept of fair pricing for medicines. BMJ. 2020; 368 https://doi.org/10.1136/bmj.l4726

National Institute for Health and Care Excellence. Flumazenil. 2021a. https//bnf.nice.org.uk/drug/flumazenil.html (accessed 18 April 2023)

National Institute of Health and Care Excellence. Naloxone hydrochloride. 2021b. https//bnf.nice.org.uk/drug/flumazenil.html (accessed 25 April 2023)

National Institute for Health and Care Excellence. Poisoning, emergency treatment. 2023. https//bnf.nice.org.uk/treatment-summary/poisoning-emergency-treatment.html (accessed 18 April 2023)

O'Connell CW, Sadler CA, Tolia VM, Ly BT, Saitman AM, Fitzgerald RL. Overdose of etizolam: the abuse and rise of a benzodiazepine analog. Ann Emerg Med. 2015; 65:(4)465-466 https://doi.org/10.1016/j.annemergmed.2014.12.019

Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2021 registrations. 2022. https//tinyurl.com/294f5evh (accessed 26 April 2023)

Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry. 2015; 72:(2)136-142 https://doi.org/10.1001/jamapsychiatry.2014.1763

Pillay VV. Current views on antidotal therapy in managing cases of poisoning and overdose. J Assoc Physicians India. 2008; 56:881-892

Reinert JP, Burnham K. Non-lactulose medication therapies for the management of hepatic encephalopathy: a literature review. J Pharm Pract. 2021; 34:(6)922-933 https://doi.org/10.1177/0897190020953024

Schmitz A. Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin. 2016; 6:(3)120-126 https://doi.org/10.9740/mhc.2016.05.120

Seelhammer TG, DeGraff EM, Behrens TJ The use of flumazenil for benzodiazepine associated respiratory depression in postanesthesia recovery: risks and outcomes. Braz J Anesthesiol. 2018; 68:(4)329-335 https://doi.org/10.1016/j.bjan.2017.12.012

Flumazenil. 2022. https//www.ncbi.nlm.nih.gov/books/NBK470180/ (accessed 18 April 2023)

Sivilotti ML. Flumazenil, naloxone and the ‘coma cocktail’. Br J Clin Pharmacol. 2016; 81:(3)428-436 https://doi.org/10.1111/bcp.12731

Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther. 1992; 14:(2)292-305

Wallace IR, Campbell EC, Trimble M. Use of a flumazenil infusion to treat chlordiazepoxide toxicity. Acute Med. 2017; 16:(1)30-34 https://doi.org/10.52964/AMJA.0649

Wang RY, Kazzi ZN. Editorial: antidotes and rescue therapies. Curr Pharm Biotechnol. 2012; 13:(10)1914-1916 https://doi.org/10.2174/138920112802273164

Waring WS. Novel acetylcysteine regimens for treatment of paracetamol overdose. Ther Adv Drug Saf. 2012; 3:(6)305-315 https://doi.org/10.1177/2042098612464265

Wise J. Prescription drug misuse in Europe is higher than previously thought. Br Med J. 2016; 354 https://doi.org/10.1w136/bmj.i4304

Use of flumazenil to treat poisoning in prehospital care

02 May 2023
Volume 15 · Issue 5

Abstract

A discussion exploring antidotes available for drug toxicity is presented, focusing specifically on flumazenil, within the prehospital setting. This critical review was carried out to establish whether this antidote would be useful in prehospital care and details the potential for practice development for the role of the ambulance-based paramedic. Analysis suggests that further research is required in order to determine the requisite of this antidote.

This critical review will explore the use of antidotes for drug toxicity in prehospital care, focusing on flumazenil as a treatment for benzodiazepine poisoning. It will detail the potential for practice development for the role of the ambulance-based paramedic.

Drug overdose (including both accidental and suicidal), drug interactions and drug toxicity secondary to incorrect drug doses can all result in toxicological emergencies, which put ever-increasing demands on the hospital and prehospital settings (Chacko and Peter, 2019).

While in-hospital mortality rates are <0.5% in acutely poisoned patients, a further 5% of patients have other serious clinical outcomes (Kuang et al, 2009). In some cases, appropriate and timely use of an antagonist or antidote can terminate the progression of toxicity; evidence suggests that administration of a specific antidote combined with general supportive care can reduce rates of morbidity and mortality related to life-threatening poisonings (Pillay, 2008). Chacko and Peter (2019) note that, conversely, inappropriate use or delayed administration may result in adverse patient outcomes.

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed